Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.

MLA

McCormick, Natalie, et al. “Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Nephrolithiasis among Patients with Pre-Existing Nephrolithiasis or Gout: Target Trial Emulation Studies.” BMJ: British Medical Journal, vol. 387, no. 8447, Nov. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1136/bmj-2024-080035.

APA

McCormick, N., Chio Yokose, Na Lu, Wexler, D. J., Aviña-Zubieta, J. A., De Vera, M. A., Chigurupati, S., Tan, K., Chixiang Chen, McCoy, R., Curhan, G. C., & Choi, H. K. (2024). Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies. BMJ: British Medical Journal, 387(8447), 1–14. https://doi.org/10.1136/bmj-2024-080035

Chicago

McCormick, Natalie, Chio Yokose, Na Lu, Deborah J. Wexler, J. Antonio Aviña-Zubieta, Mary A. De Vera, Saiajay Chigurupati, et al. 2024. “Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Nephrolithiasis among Patients with Pre-Existing Nephrolithiasis or Gout: Target Trial Emulation Studies.” BMJ: British Medical Journal 387 (8447): 1–14. doi:10.1136/bmj-2024-080035.